Search results for

Mexico's Supreme Court has tried to clarify recent amendments to the law on copyright remuneration. But, argues Luis C Schmidt of Olivares & Cia in Mexico City, many questions still remain

The TRIPs Agreement requires countries to introduce Customs measures to deal with goods that infringe trade marks and copyright. But, explains Federico A Aulmann of Obligado & Cia, Argentina has gone further by introducing legislation to tackle the import and export of goods infringing all IP rights

James Nurton interviews ASIPI president Hugo Berkemeyer about protection, enforcement and politics in IP in Latin America

Brevity can be a vital asset when arguing patent cases. Cynthia A Homan and Meredith Martin Addy of Brinks Hofer Gilson & Lione in Chicago provide some tips on how to make use of it before the Federal Circuit

Trade mark protection in Venezuela is governed by Andean Community legislation as well as national laws. José Gregorio Torrealba-Rodríguez explains some idiosyncrasies of the system, and how to challenge trade mark applications and registrations

William H Mandir, John F Rabena and Mark C Davis of Sughrue Mion, PLLC review recent case law from the International Trade Commission, and examine how accused infringers can best use the procedures available

Castor Gonzalez-Escobar of Gonzalez & Newman in Caracas provides a guide to IP enforcement in the member countries of the Andean Community, and offers some tips for rights owners

Singapore's government could soon consolidate the way that it regulates medicines and other health-related products. At the moment, the Health Sciences Authority (HSA), Singapore's equivalent of the US Food And Drug Administration (FDA), regulates medicines and other health-related products. The HSA's powers are contained in a wide variety of legislation, such as the Medicines Act, the Poisons Act, the Sale of Drugs Act and the Medicines (Advertisement and Sale) Act. Through these laws, the HSA controls the manufacture, import, distribution, promotion and sale of health-related products in Singapore.

According to criteria recently adopted by the Mexican Trade Mark Office (TMO), single invoices are appropriate and sufficient evidence to prove the use of a mark. However, it is important to point out that these criteria are contrary to doctrine and to article 62 of the Regulations of the Mexican Industrial Property Law, which establishes that a mark is in use when the goods or services covered by its registration are available in commerce in the amounts and manners that correspond to its nature.

We recently reported on a referral to the European Court of Justice, which may bring about the possibility for getting supplementary protection certificates (SPCs) for formulation patents (MIP, June 2005). This month we report on another referral to the ECJ, the outcome of which could also have a significant economic impact.